JPS6125359B2 - - Google Patents
Info
- Publication number
- JPS6125359B2 JPS6125359B2 JP838579A JP838579A JPS6125359B2 JP S6125359 B2 JPS6125359 B2 JP S6125359B2 JP 838579 A JP838579 A JP 838579A JP 838579 A JP838579 A JP 838579A JP S6125359 B2 JPS6125359 B2 JP S6125359B2
- Authority
- JP
- Japan
- Prior art keywords
- dopa
- dopamine
- streptococcus
- microorganism
- genus streptococcus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims description 51
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 claims description 28
- 241000194017 Streptococcus Species 0.000 claims description 27
- 244000005700 microbiome Species 0.000 claims description 27
- 229960003638 dopamine Drugs 0.000 claims description 25
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 claims description 24
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 13
- 239000008103 glucose Substances 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 13
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 9
- 229960004441 tyrosine Drugs 0.000 claims description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 2
- 229920000053 polysorbate 80 Polymers 0.000 claims description 2
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 claims 2
- 229960004502 levodopa Drugs 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 description 15
- 108090000790 Enzymes Proteins 0.000 description 13
- 102000004190 Enzymes Human genes 0.000 description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 238000006911 enzymatic reaction Methods 0.000 description 6
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 6
- 239000001888 Peptone Substances 0.000 description 5
- 108010080698 Peptones Proteins 0.000 description 5
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 5
- 235000011130 ammonium sulphate Nutrition 0.000 description 5
- 229940041514 candida albicans extract Drugs 0.000 description 5
- 235000019319 peptone Nutrition 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- CTENFNNZBMHDDG-UHFFFAOYSA-N Dopamine hydrochloride Chemical compound Cl.NCCC1=CC=C(O)C(O)=C1 CTENFNNZBMHDDG-UHFFFAOYSA-N 0.000 description 3
- 229960001149 dopamine hydrochloride Drugs 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 3
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 3
- 229960001327 pyridoxal phosphate Drugs 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- UHSXRTHJCJGEKG-UQKRIMTDSA-N (1s)-1-[(3,4,5-trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-2-ium-6,7-diol;chloride Chemical compound Cl.COC1=C(OC)C(OC)=CC(C[C@H]2C3=CC(O)=C(O)C=C3CCN2)=C1 UHSXRTHJCJGEKG-UQKRIMTDSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- JTWUZULPZAALRN-UHFFFAOYSA-N 3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carbaldehyde;phosphoric acid Chemical compound OP(O)(O)=O.CC1=NC=C(CO)C(C=O)=C1O JTWUZULPZAALRN-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HDYRYUINDGQKMC-UHFFFAOYSA-M acetyloxyaluminum;dihydrate Chemical compound O.O.CC(=O)O[Al] HDYRYUINDGQKMC-UHFFFAOYSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940009827 aluminum acetate Drugs 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 150000002696 manganese Chemical class 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Description
本発明は酵素法によるドーパミンの製法に関
し、更に詳しくはストレプトコツカス属に属する
微生物の生産する、L―ドーパからドーパミンを
生成する反応を触媒する酵素をL―ドーパミンに
作用させてドーパミンを製造する方法である。
ドーパミンはトリメトキノール等の医薬の合成
原料として非常に重要な化合物である。
従来よりドーパミンの製造法としては化学的合
成法による方法が多数知られているが、本発明方
法の如くL―ドーパからドーパミンを酵素的に製
造する方法についてはまだ報告されていない。
本発明者らはL―ドーパからドーパミンを生産
する能力を有する微生物を見出すべく広く検索し
た結果、ストレプトコツカス属に属する微生物、
例えばストレプトコツカス・フエカーリスが強い
L―ドーパからドーパミンを生産する能力を有す
ることを見出し、該微生物の生産する酵素をL―
ドーパに作用させれば、ほぼ定量的にドーパミン
を製造し得ることを見出した。
すなわち、本発明はL―ドーパからドーパミン
を生産する能力を有するストレプトコツカス属に
属する微生物(以下、単にストレプトコツカス属
微生物と略称する)をL―ドーパに作用させるこ
とを特徴とする酵素法によるドーパミンの製法で
ある。
本発明においてストレプトコツカス属微生物と
しては、L―ドーパからドーパミンを生産する能
力をもつストレプトコツカス属に属する微生物で
あればいずれも利用出来、例えばストレプトコツ
カス、フエカーリスATCC8043,同
ATCC11420,同ATCC11700,同ATCC12984等
があげられる。
上記ストレプトコツカス属微生物を培養する培
地としては通常の微生物の培養に繁用される各種
栄養源を使用することが出来る。炭素源としては
グルコース、シユークローズ、ラクトースおよび
マルトース等を、また窒素源および有機微量栄養
素としてはペプトン、酵母エキスおよびコーンス
チーブリカー等をそれぞれ好適に用いることが出
来る。更に無機塩としてはマグネシウム塩、マン
ガン塩、鉄塩の他、塩化アンモニウム、酢酸ナト
リウムを添加するとよい。
上記の如き培地に添加する前記L―チロシン又
はL―ドーパは培地に対して約0.1〜1%添加す
ることにより前記L―ドーパからドーパミンを生
成する反応を触媒する酵素の生産量を約5〜20倍
と飛躍的に向上せしめることが出来る。例えばス
トレプトコツカス・フエカーリスATCC12984の
培養培地にL―チロシンまたはL―ドーパを添加
しない場合、該酵素は培地1ml当り0.04単位しか
生産されないが、L―チロシンを0.5%添加した
場合は培地1ml当り約0.8単位、またL―ドーパ
を0.5%添加した場合には培地1m2当り約0.2単位
の当該酵素の生成が認められた。
また上記ストレプトコツカス属微生物の培養培
地にはポリオキシエチレンソルビタン・モノオレ
エートの如き界面活性剤を培地に対して約0.01〜
0.5%程度添加することにより該酵素の生産にと
りわけ好結果を得ることが出来る。
ストレプトコツカス属微生物の培養は、上記の
如き培地に当該微生物を接種し、静置ないし振と
うすることにより行なうことが出来る。培養は
pH約5〜8とりわけpH7で、培養温度は25℃〜
40℃とりわけ30℃〜37℃付近で好適に行なうこと
が出来、かくして菌体中の酵素は菌体の増殖と同
時に生成してくるので、菌体の生育量が最大とな
る対数増殖期の終期に最も高い酵素生産量が得ら
れる。
酵素反応は、かくして得られたストレプトコツ
カス属微生物の培養液それから分離された該微生
物の生菌体もしくはその処理物等を酵素源とし、
これを前記L―ドーパに作用させて行なうのが好
ましい。菌体処理物としては、例えば凍結乾燥菌
体、超音波処理などにより得られる無細胞抽出
液、該抽出液より精製された当該酵素等の他、生
菌体あるいは酵素を例えばポリアクリルアミドゲ
ル法、カラギーナンゲル法等の方法により固定化
して得られる固定化菌体、固定化酵素も好適に使
用することが出来る。
酵素反応に際して、酵素源としてストレプトコ
ツカス属微生物の培養液を用いる場合、該微生物
の培養開始乃至培養終期の適当時期に培養液に対
してL―ドーパを約5%程度添加して、培養乃至
反応することにより培養液中に目的とするドーパ
ミンを生成せしめることが出来る。また酵素源と
してストレプトコツカス属微生物の菌体もしくは
その処理物を用いる場合、反応液に少量のピリド
キサールリン酸を約0.001〜0.05%程度添加して
行なうのが望ましい。この場合、反応液のpH
は、4〜6とりわけ5.3にあるのが、また反応温
度は20℃〜45℃,とりわけ30℃〜37℃付近にある
のが好ましい。反応に際してグルコースを約0.5
〜5%添加すれば目的とするドーパミンの生成に
とつて好適であり、また該グルコースより生成し
た有機酸により反応液は上記pH範囲内に維持さ
れるので特にpHの調整を必要としないが、塩酸
等の鉱酸、酢酸等の有機酸を用いて上記至適pH
を維持することにより更に好結果が得られる場合
が多い。
尚、上記いずれの場合にも、酵素反応液に硫酸
アルミニウム、酢酸アルミニウム等のアルミニウ
ム塩を約0.01〜0.1%程度添加することにより、
目的とする高濃のドーパミンを定量的に生産せし
めることが出来る。
かくしてドーパミンが該反応液1ml当り30mg以
上蓄積されるが、ドーパミンは例えば反応液をろ
過して菌体その他不溶物を除去したのち濃縮液に
塩酸を加えて結晶化するか、あるいはイオン交換
樹脂処理する如き公知単離操作により容易に取得
することが出来る。
実施例 1
グルコース1%,ペプトン1%,酵母エキス
0.25%,硫酸アンモニウム0.5%,ポリオキシソ
ルビタン・モノオレエート0.2%およびL―ドー
パ0.5%含有する培地350mlをpH7に調整し、500
mlの振とうフラスコに分注したのち滅菌する。こ
れにストレプトコツカス・フエカーリス
ATCC12984を接種し、37℃,140C.p.m.にて18
時間振とう培養する。遠心分離して得た菌体を用
い
(i) 菌体0.1g,水100ml,L―ドーパ5gをけん
濁し、水酸化ナトリウムでpHを5.3に調整した
もの。
(ii) 菌体0.1g,水100ml,グルコース2g,L―
ドーパ5gをけん濁し水酸化ナトリウムでpH
を5.3に調整したもの。
(iii) 菌体0.1g,水100ml,グルコース2g,硫酸
アルミニウム、16〜18水塩0.03g,L―ドーパ
5gをけん濁し水酸化ナトリウムでpHを5.3に
調整したもの。
以上をそれぞれ37℃で、24時間反応させて、生
成したドーパミンの量を比較した。結果を表1に
示す。
The present invention relates to a method for producing dopamine using an enzymatic method, and more specifically, the present invention relates to a method for producing dopamine using an enzymatic method, and more specifically, dopamine is produced by allowing an enzyme produced by a microorganism belonging to the genus Streptococcus that catalyzes the reaction of producing dopamine from L-dopa to act on L-dopamine. It's a method. Dopamine is a very important compound as a raw material for the synthesis of pharmaceuticals such as trimethoquinol. Although many chemical synthesis methods have been known as methods for producing dopamine, a method for enzymatically producing dopamine from L-dopa, such as the method of the present invention, has not yet been reported. The present inventors conducted a wide search to find microorganisms that have the ability to produce dopamine from L-dopa, and found that microorganisms belonging to the genus Streptococcus,
For example, it was discovered that Streptococcus fuecalis has a strong ability to produce dopamine from L-dopa, and the enzyme produced by this microorganism was
It has been found that dopamine can be produced almost quantitatively by acting on dopa. That is, the present invention provides an enzymatic method characterized in that a microorganism belonging to the genus Streptococcus (hereinafter simply referred to as a microorganism of the genus Streptococcus) having the ability to produce dopamine from L-dopa is made to act on L-dopa. This is the method for producing dopamine. In the present invention, any microorganism belonging to the genus Streptococcus that has the ability to produce dopamine from L-dopa can be used as the Streptococcus microorganism, such as Streptococcus, ATCC 8043,
Examples include ATCC11420, ATCC11700, and ATCC12984. As the medium for culturing the above-mentioned microorganisms of the genus Streptococcus, various nutrient sources commonly used in the cultivation of ordinary microorganisms can be used. As carbon sources, glucose, sucrose, lactose, maltose, etc. can be suitably used, and as nitrogen sources and organic micronutrients, peptone, yeast extract, corn steep liquor, etc. can be suitably used. Further, as inorganic salts, in addition to magnesium salts, manganese salts, and iron salts, ammonium chloride and sodium acetate may be added. The amount of L-tyrosine or L-dopa added to the medium as described above is about 0.1 to 1% to the medium, thereby increasing the production amount of the enzyme that catalyzes the reaction of producing dopamine from the L-dopa by about 5 to 1%. This can be dramatically improved by 20 times. For example, when L-tyrosine or L-dopa is not added to the culture medium of Streptococcus fuecalis ATCC 12984, only 0.04 units of the enzyme are produced per ml of medium, but when 0.5% L-tyrosine is added, approximately Production of the enzyme was observed to be 0.8 units, and when 0.5% L-dopa was added, about 0.2 units per m 2 of the medium. In addition, in the culture medium of the above-mentioned Streptococcus microorganism, a surfactant such as polyoxyethylene sorbitan monooleate is added to the medium at a rate of about 0.01 to
Particularly good results can be obtained in the production of the enzyme by adding about 0.5%. Cultivation of Streptococcus microorganisms can be carried out by inoculating the microorganisms into a medium such as the one described above, and allowing the medium to stand or shake. Culture is
pH is approximately 5-8, especially pH 7, and culture temperature is 25℃ ~
It can be carried out suitably at 40°C, especially around 30°C to 37°C, and the enzymes in the bacterial cells are produced at the same time as the bacterial cells grow, so the final stage of the logarithmic growth phase, when the amount of bacterial growth is at its maximum. The highest enzyme production is obtained. The enzymatic reaction uses the culture solution of the Streptococcus microorganism thus obtained, and the viable cells of the microorganism isolated from the culture solution or its processed product as an enzyme source;
This is preferably carried out by acting on the L-dopa. Examples of processed bacterial cells include freeze-dried bacterial cells, cell-free extracts obtained by ultrasonic treatment, and the enzyme purified from the extracts, as well as live bacterial cells or enzymes that can be processed using polyacrylamide gel method, etc. Immobilized bacterial cells and immobilized enzymes obtained by immobilization by methods such as carrageenan gel method can also be suitably used. When using a culture solution of a Streptococcus microorganism as an enzyme source in an enzyme reaction, approximately 5% L-dopa is added to the culture solution at an appropriate time from the start to the end of culture of the microorganism. By reacting, the desired dopamine can be produced in the culture solution. Further, when using the cells of a Streptococcus microorganism or a processed product thereof as an enzyme source, it is desirable to add a small amount of pyridoxal phosphoric acid to the reaction solution in an amount of about 0.001 to 0.05%. In this case, the pH of the reaction solution
is preferably between 4 and 6, especially 5.3, and the reaction temperature is preferably between 20°C and 45°C, especially around 30°C and 37°C. Approximately 0.5 glucose during reaction
Addition of ~5% is suitable for producing the target dopamine, and since the reaction solution is maintained within the above pH range by the organic acid produced from the glucose, there is no need to particularly adjust the pH. Adjust the above optimal pH using a mineral acid such as hydrochloric acid or an organic acid such as acetic acid.
Even better results can often be obtained by maintaining the In any of the above cases, by adding approximately 0.01 to 0.1% of an aluminum salt such as aluminum sulfate or aluminum acetate to the enzyme reaction solution,
It is possible to quantitatively produce the desired high concentration of dopamine. In this way, more than 30 mg of dopamine is accumulated per 1 ml of the reaction solution, but dopamine can be obtained by, for example, filtering the reaction solution to remove bacterial cells and other insoluble matter, and then crystallizing it by adding hydrochloric acid to the concentrated solution, or by treating it with an ion exchange resin. It can be easily obtained by known isolation procedures such as. Example 1 Glucose 1%, peptone 1%, yeast extract
0.25% ammonium sulfate, 0.5% ammonium sulfate, 0.2% polyoxysorbitan monooleate, and 0.5% L-dopa, adjusted to pH 7,
Dispense into ml shake flasks and sterilize. In this, Streptococcus fuecalis
Inoculated with ATCC12984, 18 at 37℃, 140C.pm
Incubate with shaking for an hour. Using the bacterial cells obtained by centrifugation, (i) Suspend 0.1 g of bacterial cells, 100 ml of water, and 5 g of L-Dopa, and adjust the pH to 5.3 with sodium hydroxide. (ii) 0.1 g of bacterial cells, 100 ml of water, 2 g of glucose, L-
Suspend 5g of Dopa and adjust pH with sodium hydroxide.
adjusted to 5.3. (iii) 0.1 g of bacterial cells, 100 ml of water, 2 g of glucose, aluminum sulfate, 0.03 g of 16-18 hydrate, and 5 g of L-dopa were suspended and the pH was adjusted to 5.3 with sodium hydroxide. Each of the above was reacted at 37°C for 24 hours, and the amount of dopamine produced was compared. The results are shown in Table 1.
【表】
ドーパミン量の測定はn―ブタノール:酢酸:
水(4:1:1)の溶媒で薄層クロマトグラフイ
ーを行つた後、デンジトメータで、定量する方法
によつた。
実施例 1
グルコース1%,ペプトン1%,酵母エキス
0.25%,硫酸アンモニウム0.5%,ポリオキシソ
ルビタン、モノオレエート0.2%およびL―チロ
シン0.5%を含有する培地350mlをpH7に調整し、
500mlの振とうフラスコに分注したのち滅菌す
る。これにストレプトコツカス・フエカーリス
ATCC12984を接種し37℃,140C.p,m.にて18時
間振とう培養する。遠心分離して得た菌体の水け
ん濁液350mlに、グルコース7g,ピリドキサー
ルリン酸1mg,硫酸アルミニウム・16〜18水塩
100mgおよびL―ドーパ12gを加え30℃で48時間
反応させる。反応終了後塩酸にてpH2とし、ろ過
により菌体を除去したろ液を濃縮、次いで濃塩酸
を加えて冷却し、析出晶をろ取する。ドーパミ
ン・塩酸塩10.3gを得る。m.p.241℃(decomp)
実施例 2
グルコース1%,ペプトン1%,酵母エキス
0.25%,硫酸アンモニウム0.5%,ポリオキシソ
ルビタン・モノオレエート0.2%およびL―ドー
パ0.5%を含有する培地350mlをpH7に調整し、
500mlの振とうフラスコに分注したのち滅菌す
る。これにストレプトコツカス・フエカーリス
ATCC12984を接種し,37℃,140C.p,m.にて18
時間振とう培養する。遠心分離して得た菌体の水
けん濁液350mlに、グルコース7g,ピリドキサ
ールリン酸1mg,硫酸アルミニウム・16〜18水塩
100mgおよびL―ドーパ4gを加え、30℃で48時
間反応させる。以下、実施例1と同様に処理する
ことにより、ドーパミン・塩酸塩3.4gを得る。
実施例 3
グルコース0.5%,ペプトン1%,酵母エキス
1%,塩化アンモニウム0.5%,L―チロシン0.5
%を含有する培地350mlをpH7に調整し、500mlの
振とうフラスコに分注し滅菌する。これにストレ
プトコツカス・フエカーリスATCC12984を接種
し,37℃にて16時間振とう培養する。遠心分離し
て得た菌体を水350mlにけん濁したものにグルコ
ース3.5g、ピリドキサールリン酸1mg,硫酸ア
ルミニウム・16〜18水塩175mgおよびL―ドーパ
17.5gを加え、塩酸にてpH5.3に調整し37℃で48
時間反応させる。以下、実施例1と同様に処理し
て、ドーパミン塩酸塩15.1gを得る。[Table] The amount of dopamine is measured using n-butanol: acetic acid:
After performing thin layer chromatography with a solvent of water (4:1:1), quantitative determination was performed using a densitometer. Example 1 Glucose 1%, peptone 1%, yeast extract
0.25%, ammonium sulfate 0.5%, polyoxysorbitan, monooleate 0.2% and L-tyrosine 0.5% and adjusted to pH 7.
Dispense into 500ml shake flasks and sterilize. In this, Streptococcus fuecalis
Inoculate ATCC12984 and culture with shaking at 37℃, 140C.p, m. for 18 hours. Add 7 g of glucose, 1 mg of pyridoxal phosphate, and aluminum sulfate 16-18 hydrate to 350 ml of a suspension of bacterial cells in water obtained by centrifugation.
Add 100 mg and 12 g of L-dopa and react at 30°C for 48 hours. After the reaction is completed, the pH is adjusted to 2 with hydrochloric acid, the bacterial cells are removed by filtration, the filtrate is concentrated, concentrated hydrochloric acid is added thereto, the mixture is cooled, and the precipitated crystals are collected by filtration. Obtain 10.3g of dopamine hydrochloride. mp241℃ (decomp) Example 2 Glucose 1%, peptone 1%, yeast extract
0.25% ammonium sulfate, 0.5% ammonium sulfate, 0.2% polyoxysorbitan monooleate, and 0.5% L-dopa, adjusted to pH 7.
Dispense into 500ml shake flasks and sterilize. In this, Streptococcus fuecalis
Inoculated with ATCC12984, 18 at 37℃, 140C.p, m.
Incubate with shaking for an hour. Add 7 g of glucose, 1 mg of pyridoxal phosphate, and aluminum sulfate 16-18 hydrate to 350 ml of a suspension of bacterial cells in water obtained by centrifugation.
Add 100 mg and 4 g of L-dopa, and react at 30°C for 48 hours. Thereafter, 3.4 g of dopamine hydrochloride was obtained by processing in the same manner as in Example 1. Example 3 Glucose 0.5%, peptone 1%, yeast extract 1%, ammonium chloride 0.5%, L-tyrosine 0.5
Adjust 350 ml of medium containing % to pH 7, dispense into 500 ml shake flasks and sterilize. This is inoculated with Streptococcus fuecalis ATCC12984, and cultured with shaking at 37°C for 16 hours. The cells obtained by centrifugation were suspended in 350 ml of water, and 3.5 g of glucose, 1 mg of pyridoxal phosphate, 175 mg of aluminum sulfate 16-18 hydrate and L-dopa were added.
Add 17.5g, adjust the pH to 5.3 with hydrochloric acid, and raise to 48% at 37℃.
Allow time to react. Thereafter, the same treatment as in Example 1 is carried out to obtain 15.1 g of dopamine hydrochloride.
Claims (1)
有するストレプトコツカス属に属する微生物をL
―ドーパに作用させてドーパミンを生成させるこ
とを特徴とするドーパミンの製法。 2 ストレプトコツカス属に属する微生物がスト
レプトコツカス・フエカーリスである特許請求の
範囲第2項記載の製法。 3 ストレプトコツカス属に属する微生物をL―
ドーパに作用させるに際して、反応後にグルコー
スを約0.5〜約5%添加する特許請求の範囲第1
項記載の製法。 4 ストレプトコツカス属に属する微生物をL―
ドーパに作用させるに際して、反応後にアルミニ
ウム塩を約0.01〜約0.1%添加する特許請求の範
囲第3項記載の製法。 5 ストレプトコツカス属に属する微生物をL―
ドーパにpH約4.5〜7,温度約20℃〜約45℃で作
用させる特許請求の範囲第3項、第4項記載の製
法。 6 ストレプトコツカス属に属する微生物をL―
ドーパに作用させバーパミンを生成させるに際
し、該微生物を、L―チロシンまたはL―ドーパ
の存在下に培養する特許請求の範囲第1項または
第2項記載の製法。 7 ストレプトコツカス属に属する微生物をL―
ドーパに作用させてドーパミンを生成させるに際
し、培地にポリオキシエチレンソルビタン・モノ
オレエートを約0.01〜約0.5%添加して該微生物
を培養する特許請求の範囲第6項記載の製法。[Claims] 1. A microorganism belonging to the genus Streptococcus that has the ability to produce dopamine from L-dopa is
- A method for producing dopamine, which is characterized by producing dopamine by acting on dopa. 2. The production method according to claim 2, wherein the microorganism belonging to the genus Streptococcus is Streptococcus fuecalis. 3 Microorganisms belonging to the genus Streptococcus are
Claim 1: When acting on dopa, glucose is added in an amount of about 0.5 to about 5% after the reaction.
Manufacturing method described in section. 4 Microorganisms belonging to the genus Streptococcus are
4. The method according to claim 3, wherein about 0.01 to about 0.1% of aluminum salt is added after the reaction when acting on DOPA. 5 Microorganisms belonging to the genus Streptococcus are
The manufacturing method according to claims 3 and 4, wherein DOPA is allowed to act at a pH of about 4.5 to 7 and a temperature of about 20°C to about 45°C. 6 Microorganisms belonging to the genus Streptococcus are
3. The production method according to claim 1 or 2, wherein the microorganism is cultured in the presence of L-tyrosine or L-dopa when producing vapamine by acting on dopa. 7 Microorganisms belonging to the genus Streptococcus are
7. The production method according to claim 6, wherein the microorganism is cultured by adding about 0.01 to about 0.5% polyoxyethylene sorbitan monooleate to the medium when producing dopamine by acting on dopa.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP838579A JPS55102394A (en) | 1979-01-26 | 1979-01-26 | Novel enzymatic preparation of dopamine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP838579A JPS55102394A (en) | 1979-01-26 | 1979-01-26 | Novel enzymatic preparation of dopamine |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS55102394A JPS55102394A (en) | 1980-08-05 |
JPS6125359B2 true JPS6125359B2 (en) | 1986-06-14 |
Family
ID=11691741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP838579A Granted JPS55102394A (en) | 1979-01-26 | 1979-01-26 | Novel enzymatic preparation of dopamine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS55102394A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0630566B2 (en) * | 1983-03-02 | 1994-04-27 | 株式会社ニツピ | Selective enrichment medium for hemolytic streptococcus |
EP0859060A3 (en) * | 1997-02-14 | 2000-07-26 | DAICEL CHEMICAL INDUSTRIES, Ltd. | Method of producing D-amino acid and amine |
WO2019060661A1 (en) * | 2017-09-22 | 2019-03-28 | Iowa State University Research Foundation, Inc. | Probiotic compositions for production of dopamine |
-
1979
- 1979-01-26 JP JP838579A patent/JPS55102394A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS55102394A (en) | 1980-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4080259A (en) | Process of preparing L and D α-amino acids by enzyme treatment of DL-α-amino acid amide | |
JPS6320520B2 (en) | ||
JPH0218072B2 (en) | ||
JP3951008B2 (en) | Capsaicin decomposing / synthesizing enzyme and production method thereof | |
JPS63273486A (en) | Production of 1-(4-methoxyphenyl)-2-aminopropane | |
JPS6125359B2 (en) | ||
JPS6129953B2 (en) | ||
JP3116102B2 (en) | Method for producing L-3,4-dihydroxyphenylalanine | |
JPH01320991A (en) | Production of d-homophenylalanines | |
JP2009225705A (en) | Method for producing theanine | |
JPH06141888A (en) | Production of d-mandelic acid | |
JPH0148758B2 (en) | ||
JPS58201992A (en) | Preparation of beta-substituted propionic acid or amide thereof by microorganism | |
JPS61274690A (en) | Production of d-alpha-amino acid | |
JPS6319158B2 (en) | ||
JPH04341195A (en) | Production of optically active mandelic acid | |
JPH01104194A (en) | Production of d-(-)-tartaric acid | |
KR910007849B1 (en) | New microorganism stretomyces spy-183 | |
JP2674076B2 (en) | Method for producing D-α-amino acid | |
JPS63219389A (en) | Production of di-d-fructosylfuranose 1,2':2,3' dianhydride | |
JPH0591895A (en) | Production of d-serine | |
JPH04152895A (en) | Production of optically active 1,3-butanediol | |
GB1577087A (en) | Enzyme preparation having l-amino acyl amidase activity | |
JPS6243679B2 (en) | ||
JPS61260889A (en) | Production of calcium malate |